Effect of Mesenchymal Stem Cells(MSCs) Transplantation for Acute Cerebral Infarction Patients

A phase 1/2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 120 participants.

Also called NCT04093336

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 1/2
Enrolled
  • 120 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04093336
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT04093336. Randomized; quadruple masking; primary purpose treatment. Start 2019-01-13 (actual); primary completion 2024-12-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Effect of Mesenchymal Stem Cells(MSCs) Transplantation for Acute Cerebral Infarction Patients
Condition
Infarction, Middle Cerebral Artery
Condition
Infarction, Anterior Cerebral Artery
Condition
Cerebral Infarction
Condition
Stroke, Ischemic
Condition
Acute Stroke
Condition
Brain Infarction
Condition
Infarction, PCA
Condition
Infarction, Posterior Circulation, Brain
Intervention (Biological)
human umbilical cord mesenchymal stem cells
Intervention (Biological)
Placebo
Intervention (Other)
standardized treatment
Lead sponsor
Shanghai East Hospital (class: other)

Record details

Record id
cardio:ct-nct04093336
Content hash
983482e2537aa01cecbb22e5cc889b8d4c89da0be5ad094fbf6cb5c4ac2c0259